Schedule of stock-based compensation expense related to all of the entity's stock-based awards |
Total stock-based compensation expense related to all of our stock-based awards was as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
|
2012 |
|
2011 |
|
2010 |
|
Research and development
|
|
$ |
7,050 |
|
$ |
9,277 |
|
$ |
9,025 |
|
General and administrative
|
|
|
5,567 |
|
|
3,891 |
|
|
7,411 |
|
|
|
|
|
|
|
|
|
Total stock-based compensation expense
|
|
$ |
12,617 |
|
$ |
13,168 |
|
$ |
16,436 |
|
|
|
|
|
|
|
|
|
|
Schedule of option activity under equity incentive plans |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares
Available
For Grant |
|
Number of
Shares
Underlying
Options |
|
Weighted-
Average
Exercise Price |
|
Weighted-
Average
Remaining
Contractual Term
(in years) |
|
Aggregate
Intrinsic
Value |
|
Outstanding at January 1, 2010
|
|
|
2,793,690 |
|
|
7,914,869 |
|
$ |
14.32 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authorized for grant
|
|
|
1,600,000 |
|
|
— |
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
(1,957,020 |
) |
|
1,957,020 |
|
$ |
8.60 |
|
|
|
|
|
|
|
Exercised
|
|
|
— |
|
|
(86,459 |
) |
$ |
6.60 |
|
|
|
|
|
|
|
Cancelled
|
|
|
91,429 |
|
|
(91,429 |
) |
$ |
16.04 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at December 31, 2010
|
|
|
2,528,099 |
|
|
9,694,001 |
|
$ |
13.22 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authorized for grant
|
|
|
4,350,000 |
|
|
— |
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
(2,236,270 |
) |
|
2,236,270 |
|
$ |
6.80 |
|
|
|
|
|
|
|
Exercised
|
|
|
— |
|
|
(114,988 |
) |
$ |
6.67 |
|
|
|
|
|
|
|
Cancelled
|
|
|
65,924 |
|
|
(65,924 |
) |
$ |
10.95 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at December 31, 2011
|
|
|
4,707,753 |
|
|
11,749,359 |
|
$ |
12.07 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authorized for grant
|
|
|
600,000 |
|
|
— |
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
(2,149,266 |
) |
|
2,149,266 |
|
$ |
8.13 |
|
|
|
|
|
|
|
Exercised
|
|
|
— |
|
|
(254,149 |
) |
$ |
7.08 |
|
|
|
|
|
|
|
Cancelled
|
|
|
40,099 |
|
|
(40,099 |
) |
$ |
19.60 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at December 31, 2012
|
|
|
3,198,586 |
|
|
13,604,377 |
|
$ |
11.52 |
|
|
5.76 |
|
$ |
16,768 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vested and expected to vest at December 31, 2012
|
|
|
|
|
|
13,569,092 |
|
$ |
11.53 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable at December 31, 2012
|
|
|
|
|
|
12,841,378 |
|
$ |
11.75 |
|
|
5.59 |
|
$ |
16,729 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable at December 31, 2011
|
|
|
|
|
|
10,982,934 |
|
$ |
12.38 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable at December 31, 2010
|
|
|
|
|
|
8,934,275 |
|
$ |
13.34 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average grant date fair value of options granted during 2012, 2011 and 2010 was $5.44, $4.63 and $6.14, respectively.
|
Schedule of stock options by exercise price |
Details of our stock options by exercise price are as follows as of December 31, 2012:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options Outstanding |
|
|
|
|
|
|
|
Options Exercisable |
|
|
|
|
|
Weighted-Average
Remaining
Contractual Life
(in years) |
|
|
|
Exercise Price
|
|
Number of
Shares Underlying
Options |
|
Weighted-Average
Exercise Price |
|
Number of
Shares Underlying
Options |
|
Weighted-Average
Exercise Price |
|
$6.48 - $6.49
|
|
|
1,675,636 |
|
|
6.24 |
|
$ |
6.49 |
|
|
1,671,713 |
|
$ |
6.49 |
|
$6.50 - $6.73
|
|
|
2,406,410 |
|
|
7.96 |
|
|
6.72 |
|
|
2,145,582 |
|
|
6.70 |
|
$6.74 - $8.15
|
|
|
2,924,346 |
|
|
7.74 |
|
|
7.97 |
|
|
2,494,317 |
|
|
7.96 |
|
$8.16 - $9.59
|
|
|
1,267,156 |
|
|
1.98 |
|
|
8.44 |
|
|
1,231,653 |
|
|
8.44 |
|
$9.60 - $11.23
|
|
|
1,587,992 |
|
|
6.25 |
|
|
9.79 |
|
|
1,555,276 |
|
|
9.79 |
|
$11.24 - $23.93
|
|
|
1,960,633 |
|
|
3.04 |
|
|
17.36 |
|
|
1,960,633 |
|
|
17.36 |
|
$23.94 - $26.45
|
|
|
1,782,204 |
|
|
4.36 |
|
|
25.88 |
|
|
1,782,204 |
|
|
25.88 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$6.48 - $26.45
|
|
|
13,604,377 |
|
|
5.76 |
|
$ |
11.52 |
|
|
12,841,378 |
|
$ |
11.75 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|